Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Report date January 15, 2025 · Filed January 17, 2025
Section 16 reporting ended · disclosed 2025-01-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 369,183 |
Reported balance
After 2025-01-15 transaction · row 1
1 source rowRow 1 · 2025-01-15 · Tax withholding · Disposed 54,412 · Balance 369,183 F1: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2025 Filed Jan 17, 2025 16:19 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Tax withholdingClass A Common Stock | 54,412 | $4.56 | $248,118.72 |
DisclosureSEC source: 0001823239-25-000014 · wk-form4_1737148739.xml · nonDerivative · entry 1 BURCH ANDREW · CIK 0001970770 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369,183 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. Read SEC document |
| October 31, 2024 Filed Nov 12, 2024 16:59 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 1,841 | $5.70 | $10,493.70 |
DisclosureSEC source: 0001823239-24-000112 · wk-form4_1731448762.xml · nonDerivative · entry 1 BURCH ANDREW · CIK 0001970770 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 423,595 F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,841 shares of Class A Common Stock was exempt pursuant to Rule 16b-3. Read SEC document |
| April 30, 2024 Filed May 2, 2024 18:46 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 1,719 | $5.70 | $9,798.30 |
DisclosureSEC source: 0001823239-24-000054 · wk-form4_1714689973.xml · nonDerivative · entry 1 BURCH ANDREW · CIK 0001970770 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 421,754 F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,719 shares of Class A Common Stock was exempt pursuant to Rule 16b-3. Read SEC document |
| April 15, 2024 Filed Apr 16, 2024 18:01 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Tax withholdingClass A Common Stock | 16,758 | $8.11 | $135,907.38 |
DisclosureSEC source: 0001823239-24-000046 · wk-form4_1713304888.xml · nonDerivative · entry 1 BURCH ANDREW · CIK 0001970770 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,035 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 18:32 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 295,782 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001823239-24-000018 · wk-form4_1705620742.xml · nonDerivative · entry 1 BURCH ANDREW · CIK 0001970770 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 436,793 F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in one-half (1/2) increments on each of January 15, 2025, and January 15, 2026, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| April 17, 2023 Filed Jan 18, 2024 18:15 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantEmployee Stock Options (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $14.14 | $0.00 |
DisclosureSEC source: 0001823239-24-000002 · wk-form5_1705619708.xml · derivative · entry 2 BURCH ANDREW · CIK 0001970770 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Class A Common Stock · 80,000 shares Expires 2033-04-17 F2 · derivative.exercise_date: Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 25% on April 15, 2024 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| April 17, 2023 Filed Jan 18, 2024 18:15 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 141,011 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001823239-24-000002 · wk-form5_1705619708.xml · nonDerivative · entry 1 BURCH ANDREW · CIK 0001970770 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,011 F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in 1/3rd increments on each of April 15, 2024, April 15, 2025, and April 15, 2026, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.